Joan Murphy1, Erin B Kennedy2, Sheila Dunn3, C Meg McLachlin4, Michael Fung Kee Fung5, Danusia Gzik6, Michael Shier7, Lawrence Paszat8. 1. Division of Gynecologic Oncology, University Health Network, Toronto ON. 2. Program in Evidence-based Care, Cancer Care Ontario and Department of Oncology, McMaster University, Hamilton ON. 3. Family Practice Unit, Women's College Hospital, Toronto ON. 4. London Health Sciences Centre, London ON. 5. Ottawa General Hospital, Ottawa ON. 6. North Simcoe Muskoka Local Health Integration Network, Huntsville ON. 7. Sunnybrook Health Sciences Centre, Toronto ON. 8. Institute for Clinical Evaluative Sciences, Toronto ON.
Abstract
OBJECTIVE: To develop guidelines to inform the Ontario Cervical Screening Program's invitations to women in the target population, provide evidence-based clinical practice guidance for practitioners, and inform policy decisions. METHODS: A systematic review was conducted of relevant websites, the Medline and EMBASE databases (2005 to November 2010), and the Cochrane Library (2005 to 2010). No guidelines or systematic reviews were located that addressed the topics of interest. The evidence base consisted of seven randomized controlled trials, three case-control studies, one cohort study, and one review article. A methodologist performed data identification and extraction. Review of the data and quality assessment was carried out by the authors, who have expertise in methodology, gynaecologic oncology, pathology, and family medicine. The systematic review methods and resulting recommendations were reviewed by an internal panel with clinical, methodological, and oncology expertise. External review was provided by Ontario clinicians and other experts. CONCLUSIONS: The guideline development process led to recommendations for the optimal primary cervical screening method, screening interval, and age of screening cessation for Ontario women in the target population. There was insufficient evidence to provide a recommendation for age of initiation of cervical screening with HPV testing. The creation of an organized screening program in the province will allow the implementation of evidence-based recommendations. We provide interim recommendations for cervical screening until HPV testing has been funded.
OBJECTIVE: To develop guidelines to inform the Ontario Cervical Screening Program's invitations to women in the target population, provide evidence-based clinical practice guidance for practitioners, and inform policy decisions. METHODS: A systematic review was conducted of relevant websites, the Medline and EMBASE databases (2005 to November 2010), and the Cochrane Library (2005 to 2010). No guidelines or systematic reviews were located that addressed the topics of interest. The evidence base consisted of seven randomized controlled trials, three case-control studies, one cohort study, and one review article. A methodologist performed data identification and extraction. Review of the data and quality assessment was carried out by the authors, who have expertise in methodology, gynaecologic oncology, pathology, and family medicine. The systematic review methods and resulting recommendations were reviewed by an internal panel with clinical, methodological, and oncology expertise. External review was provided by Ontario clinicians and other experts. CONCLUSIONS: The guideline development process led to recommendations for the optimal primary cervical screening method, screening interval, and age of screening cessation for Ontario women in the target population. There was insufficient evidence to provide a recommendation for age of initiation of cervical screening with HPV testing. The creation of an organized screening program in the province will allow the implementation of evidence-based recommendations. We provide interim recommendations for cervical screening until HPV testing has been funded.
Authors: Ciara Pendrith; Meghan Bhatia; Noah M Ivers; Graham Mecredy; Karen Tu; Gillian A Hawker; Susan B Jaglal; Lynn Wilson; Kimberly Wintemute; Richard H Glazier; Wendy Levinson; R Sacha Bhatia Journal: CMAJ Open Date: 2017-01-20
Authors: Tali Bogler; Allison Farber; Nathan Stall; Sheila Wijayasinghe; Morgan Slater; Charlie Guiang; Richard H Glazier Journal: Can Fam Physician Date: 2015-10 Impact factor: 3.275
Authors: H N Pedersen; L W Smith; C Sarai Racey; D Cook; M Krajden; D van Niekerk; G S Ogilvie Journal: Curr Oncol Date: 2018-02-28 Impact factor: 3.677
Authors: Germaine Wong; Jade S Hayward; Eric McArthur; Jonathan C Craig; Danielle M Nash; Stephanie N Dixon; Deborah Zimmerman; Abhijat Kitchlu; Amit X Garg Journal: Clin J Am Soc Nephrol Date: 2016-12-29 Impact factor: 8.237
Authors: Cornelia M Borkhoff; Refik Saskin; Linda Rabeneck; Nancy N Baxter; Ying Liu; Jill Tinmouth; Lawrence F Paszat Journal: Can J Public Health Date: 2013-06-21